Ignite Creation Date:
2024-05-06 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03512197
Status:
COMPLETED
Last Update Posted:
2023-08-21
First Post:
2018-03-26
Brief Title:
A Global Study of the Efficacy and Safety of Midostaurin Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative FLT3-MN Acute Myeloid Leukemia AML
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-12
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-26
First Submit QC Date:
April 18 2018
Study First Post Date:
2018-04-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-06-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-16
Last Update Post Date:
2023-08-21
Last Update Post Date Type:
ACTUAL